Trends in antimicrobial resistance in Israel, 2014-2017
- PMID: 31171967
- PMCID: PMC6549337
- DOI: 10.1186/s13756-019-0535-1
Trends in antimicrobial resistance in Israel, 2014-2017
Abstract
We analyzed Israeli national data on antimicrobial susceptibility from bloodstream isolates collected between 2014 and 2017 and compared resistance proportions with those of Europe. The incidence of bloodstream infection (BSI) caused by most antibiotic-resistant organisms remained unchanged or decreased. An exception was increased incidence of BSI caused by third-generation cephalosporin-resistant Escherichia coli. Overall, resistance proportions were similar to those observed in southern Europe, with the exception of a lower proportion of carbapenem-resistant Klebsiella pneumoniae in Israel.
Keywords: Antibiogram; Antibiotic; Bloodstream isolate; CRE; ESBL; Israel; MRSA; Resistance; Surveillance; VRE.
Conflict of interest statement
Competing interestsThe authors declare that they have no competing interests.
References
-
- European Committee on Antimicrobial Susceptibility Testing (EUCAST). EUCAST warnings concerning antimicrobial susceptibility testing products or procedures. Available from: http://www.eucast.org/ast_of_bacteria/warnings/#c13111. Accessed 6 May 2019.
-
- The World Bank Group. Available from: https://www.worldbank.org/. Accessed 6 May 2019.
-
- Israeli Ministry of Health. [In-patient institutions and units for day hospitalization in Israel 2014]. Available from: https://www.health.gov.il/publicationsfiles/mosadot2014_p2.pdf. Accessed 6 May 2019.
-
- Israeli Ministry of Health. [In-patient institutions and units for day hospitalization in Israel 2015]. Available from: https://www.health.gov.il/publicationsfiles/mosadot2015_p2.pdf. Accessed 6 May 2019.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical